North America And Europe Pharmaceutical Stability & Storage Services Market (By Services: Stability, Storage; By Molecule: Large Molecule, Small Molecule; By Mode) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The North America and Europe pharmaceutical stability & storage services market was surpassed at USD 2.25 billion in 2023 and is expected to hit around USD 3.85 billion by 2033, growing at a CAGR of 5.53% from 2024 to 2033.

Key Pointers

• By Service, the stability testing services segment held the largest revenue share of 74% in 2023.
• By Service, the storage segment is expected to witness a higher CAGR of 6.14% from 2024 to 2033.
• By Molecules, the small molecules segment generated the maximum market share of 65% in 2023.
• By Mode, the in-house segment contributed the largest market share of 62% in 2023.

North America And Europe Pharmaceutical Stability & Storage Services Market Overview

The pharmaceutical industry is highly regulated and demands stringent adherence to stability and storage standards to ensure the safety and efficacy of drugs. Pharmaceutical stability and storage services play a crucial role in maintaining product quality throughout the drug development and distribution process. This overview delves into the North America and Europe pharmaceutical stability & storage services market, providing insights into its dynamics, trends, and key players.

North America And Europe Pharmaceutical Stability & Storage Services Market Growth 

The growth of the North America and Europe pharmaceutical stability & storage services market is propelled by various factors. Firstly, the increasing complexity of drug formulations necessitates precise stability testing and storage conditions, driving demand for specialized services. Additionally, stringent regulatory requirements in these regions mandate adherence to strict quality standards, creating a need for reliable stability and storage solutions. Moreover, the rising trend of outsourcing among pharmaceutical companies seeking cost-efficiency and expertise further fuels market growth. Technological advancements in monitoring systems and a growing emphasis on sustainable practices also contribute to the expansion of this market segment. Overall, these factors collectively drive the growth of the pharmaceutical stability & storage services market in North America and Europe, presenting opportunities for providers to meet the evolving needs of the industry.

Report Scope of the North America And Europe Pharmaceutical Stability & Storage Services Market

North America And Europe Pharmaceutical Stability & Storage Services Market Trends:

• Outsourcing Trend: Pharmaceutical companies in North America and Europe are increasingly outsourcing stability and storage services to specialized third-party providers to reduce costs, mitigate risks, and access advanced expertise.
• Regulatory Compliance Focus: With regulatory agencies tightening their oversight, there's a heightened focus on ensuring compliance with stability testing and storage regulations, driving the demand for specialized service providers.
• Quality Management Emphasis: Quality management systems are integral to pharmaceutical stability and storage services, with providers implementing robust quality control measures to maintain product integrity and meet regulatory requirements.
• Sustainable Practices Adoption: There's a growing emphasis on adopting environmentally sustainable practices in pharmaceutical stability and storage, including energy-efficient facilities, eco-friendly packaging materials, and waste reduction strategies.

Service Insights

The stability testing services segment dominated the pharmaceutical stability & storage services market in North America and Europe, accounting for 74% of the overall revenue share in 2023. Stability testing provides data on the changes in the quality of a drug product or drug substance over time, as influenced by various environmental factors including temperature, humidity, and light. Its objective is to determine a re-test period for the drug substance or shelf life for the drug product, along with the recommended storage conditions for it.

On the other hand, the storage segment is expected to witness a higher CAGR of 6.14% over the forecast period. Most players outsource their drug stability and storage management function, as it offers several advantages such as cost reduction, risk mitigation, and operational efficiency, which can drive segment growth. By partnering with companies with GMP-compliant facilities and experienced staff, organizations can streamline their stability studies and focus on their core competencies.

Molecules Insights

The small molecules segment dominated the North America and Europe pharmaceutical stability & storage services market, with 65% of the revenue share in 2023. Most pharmaceutical medications comprise small molecules, amounting to about 90% of all drugs. These medications treat fever, migraines, cancer, diabetes, and other common disorders. Small-molecule medications are used to treat numerous illnesses and disorders, which increases the need for stable testing and storage.

On the other hand, the large molecules segment is expected to show significant growth during the forecast period. The increasing demand for biological products such as tissues, recombinant therapeutic proteins, blood & blood components, allergens, somatic cells, and vaccinations drives segment growth. FDA states that biologics, despite being difficult and time-consuming to develop, may eventually prove to be the most effective means of treating a variety of medical illnesses and diseases for which no other medicines are available.

Mode Insights

The in-house segment led the North America and Europe market for pharmaceutical stability & storage services, accounting for 62% of the revenue share in 2023. Conducting stability testing in-house can be more cost-effective than outsourcing it to external laboratories. It gives companies greater control over the testing process, reduces turnaround times, and allows for more efficient resource allocation. These factors collectively drive the need for in-house stability testing, enabling companies to meet regulatory requirements, ensure product quality & safety, optimize formulations, and enhance customer satisfaction.

On the other hand, the outsourcing segment is expected to show significant market growth in the coming years. Stability testing is crucial to product development and quality control, especially in the pharmaceutical & healthcare industries. Outsourcing allows access to specialized expertise and experience in stability testing. External laboratories or CROs often have dedicated teams with in-depth knowledge of regulatory requirements, testing methodologies, and data analysis techniques, which drives their demand.

North America And Europe Pharmaceutical Stability & Storage Services Market Key Companies

• Eurofins Scientific
• Intertek Group plc
• Lucideon Limited
• Element Materials Technology
• Q1 Scientific
• Reading Scientific Services Ltd.
• Catalent, Inc.
• Quotient Sciences
• Recipharm AB
• Almac Group
• Alcami Corporation
• BioLife Solutions, Inc.
• Sampled (Roylance Stability Storage Limited)
• Precision Stability Storage
• Broughton

North America And Europe Pharmaceutical Stability & Storage Services Market Segmentations:

By Service 

• Stability
  • Drug Substance
  • Stability indicating method validation
  • Accelerated stability testing
  • Photostability Testing
  • Other stability testing methods
• Storage
  • Cold
  • Non-cold

By Molecules 

• Small Molecule
  • Research Products
  • Commercial Products
• Large Molecule
  • Research Products
  • Commercial Products

By Mode 

• In-house
• Outsourcing